Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GW.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.40EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.2.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.367EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.367EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KG.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
KG.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HA.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HA.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.351 (Beta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.351 (Beta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.36EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HZ.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.396EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.396EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.129EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.129EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AK.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.20EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
C.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.221.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.221.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.224EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.224EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.6.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.4.6.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBJEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XBJEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EJ.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EJ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DQ.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AG.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.258.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
W.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used